Cours suspendu

Communiqués SurModics

Actions

SRDX

US8688731004

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/11/2025			Varia. 5j.	Varia. 1 janv.
42,98 ^USD	+0,35%		-.--%	-

19/05	Endologix LLC fait l'acquisition du système de thrombectomie Pounce auprès de Surmodics, Inc.	CI
10/12	Surmodics, Inc. acquiert certains actifs de Biocoat, Incorporated	CI

Communiqués

25/11	GTCR/Surmodics Win On Divestiture, Share Analysis And Captive Capacity	AQ
17/11	Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today	BU
11/11	Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR	BU
04/11	Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations	BU
03/11	Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3	BU
29/10/25	Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform	BU
27/10/25	Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28	BU
08/08/25	SurModics: Fiscal Q3 Earnings Snapshot	AQ
08/08/25	Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance	BU
06/08/25	Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8	BU
30/04/25	SurModics: Fiscal Q2 Earnings Snapshot	AQ
30/04/25	Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance	BU
29/04/25	Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30	BU
23/04/25	Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil Drug-Coated Balloon	AQ
22/04/25	Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon	BU
17/04/25	Two-Minute Recap Of Competition Law Matters Around The Globe	AQ
04/04/25	Surmodics Announces Commercial Release of Pounce XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries	AQ
03/04/25	Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries	BU
17/03/25	Client Alert: FTC Challenges Medical Device Coating Transaction	AQ
14/03/25	GTCR / Surmodics: Four Key Takeaways For M&A Antitrust From The First FTC Merger Challenge Under Trump	AQ
14/03/25	FTC's First Merger Challenge Under New Leadership Signals Return To Traditional Antitrust Theories In Private Equity Deals	AQ
07/03/25	Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR	BU
03/02/25	Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries	BU
30/01/25	SurModics: Fiscal Q1 Earnings Snapshot	AQ
30/01/25	Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results	BU